BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6516679)

  • 1. Reduced intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with jejunoileal bypass.
    Sundqvist T; Magnusson KE; Larsson L; Tagesson C; Backman L; Nordenvall B
    Acta Chir Scand; 1984; 150(7):567-71. PubMed ID: 6516679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complex pathogenesis of hyperoxaluria after jejunoileal bypass surgery. Oxalogenic substances in diet contribute to urinary oxalate.
    Hofmann AF; Laker MF; Dharmsathaphorn K; Sherr HP; Lorenzo D
    Gastroenterology; 1983 Feb; 84(2):293-300. PubMed ID: 6848409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-oxalate, low-fat dietary regimen in hyperoxaluria following jejunoileal bypass.
    Nordenvall B; Backman L; Burman P; Larsson L; Tiselius HG
    Acta Chir Scand; 1983; 149(1):89-91. PubMed ID: 6837228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered intestinal permeability to low-molecular-weight polyethyleneglycols (PEG 400) in patients with Crohn's disease.
    Magnusson KE; Sundqvist T; Sjödahl R; Tagesson C
    Acta Chir Scand; 1983; 149(3):323-7. PubMed ID: 6613469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperoxaluria associated with intestinal bypass surgery for morbid obesity: occurrence, pathogenesis and approaches to treatment.
    Hofmann AF; Schmuck G; Scopinaro N; Laker MF; Sherr HP; Lorenzo D; Meeuse BJ
    Int J Obes; 1981; 5(5):513-8. PubMed ID: 6796533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Passage of molecules through the wall of the gastrointestinal tract. Intestinal permeability to polyethyleneglycol 1 000 in patients with Crohn's disease.
    Heuman R; Sjödahl R; Tagesson C
    Acta Chir Scand; 1982; 148(3):281-4. PubMed ID: 7136430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute reversible renal failure following jejunoileal bypass for morbid obesity: a clinical and pathological (EM) study of a case.
    Ehlers SM; Posalaky Z; Strate RG; Quattlebaum FW
    Surgery; 1977 Nov; 82(5):629-34. PubMed ID: 918850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conversion of malfunctioning intestinal bypass to gastric bypass.
    Saporta JA; Cegielski MM; Organ CH
    Surg Gynecol Obstet; 1980 Dec; 151(6):801-2. PubMed ID: 7444733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium in the treatment of diarrhoea and hyperoxaluria after jejunoileal bypass for obesity.
    Stokholm KH; Abildgaard U
    Int J Obes; 1980; 4(2):105-10. PubMed ID: 7399801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass.
    Nordenvall B; Backman L; Larsson L; Tiselius HG
    Acta Chir Scand; 1983; 149(1):93-8. PubMed ID: 6837229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Jejunoileal bypass for the treatment of morbid obesity.
    Buchwald H
    Int Surg; 1980; 65(2):103-5. PubMed ID: 7216653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxalosis and chronic renal failure after intestinal bypass.
    Gelbart DR; Brewer LL; Fajardo LF; Weinstein AB
    Arch Intern Med; 1977 Feb; 137(2):239-43. PubMed ID: 836109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fat and nitrogen balances after jejunoileal bypass for obesity (author's transl)].
    Beno I; Rozhold J; Chorváthová V; Prikazská M; Virsik A; Siman J
    Dtsch Z Verdau Stoffwechselkr; 1980; 40(5):184-91. PubMed ID: 7449716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metronidazole treatment of bypass-enteropathy after jejunoileal shunt-operation for obesity.
    Paerregaard A; Justesen T; Prytz H; Andersen B; Gudmand-Hoeyer E
    Acta Chir Scand; 1982; 148(2):153-6. PubMed ID: 7148311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased gastrointestinal absorption of peroral polyethyleneglycols (PEG 1000) in Crohn's disease. A sign of jejunal abnormality.
    Olaison G; Sjödahl R; Tagesson C
    Acta Chir Scand; 1987; 153(5-6):373-7. PubMed ID: 3661039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fate of weight. Ten-year observations after jejunoileal bypass for obesity.
    Wiklund B
    Acta Chir Scand; 1982; 148(5):443-52. PubMed ID: 7180342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aspects of the ambulatory control of morbid obesity patients subjected to a jejunoileal bypass].
    Scaravaggi V; Vita PM; Lattuada E; Apollo A; Spezzano G
    Minerva Chir; 1984 Oct; 39(20):1373-7. PubMed ID: 6521898
    [No Abstract]   [Full Text] [Related]  

  • 18. Evolution of liver disease in morbid obesity after small-intestinal bypass and its restoration. A case report.
    Allam C; Bala'a M; Shamma'a M
    Arch Pathol Lab Med; 1983 Apr; 107(4):195-8. PubMed ID: 6687540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Jejunoileal bypass on account of obesity. Function of the blind intestinal loop (author's transl)].
    Príkazská M; Beno I; Rozhold J
    Cesk Gastroenterol Vyz; 1982 Jan; 36(1):21-5. PubMed ID: 7060145
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of PEEP on arterial oxygenation during jejunoileal bypass surgery for the treatment of morbid obesity].
    Comelli LF; Pignatelli MG; Rolla G; Tesselli L; Varrassi G; Gianferrari P; Prioglio S; Costa P
    Minerva Anestesiol; 1983 Mar; 49(3):111-8. PubMed ID: 6343920
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.